TheStreet Quant Ratings rates Cell Therapeutics Inc (NASDAQ:CTIC) as a sell. The company’s weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow. Cell Therapeutics Inc (NASDAQ:CTIC) stock opened at $4.16 in last trading session, and closed at $4.13, trading in the range of $3.88 – $4.20. The stock showed a positive weekly performance of 35.41%.
Novavax, Inc. (NASDAQ:NVAX) average recommendation is buy with average Target Price of $8.70. Novavax, Inc. (NASDAQ:NVAX) shares closed at $6.40 on last trade day, by gaining 0.63%. Stock 52 week range is $1.68 – $6.49. Company’s market capitalization is $1.33 billion.
TheStreet Ratings rates Vector Group Ltd (NYSE:VGR) as a hold. Vector Group Ltd (NYSE:VGR)‘s strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company’s earnings per share and deteriorating net income. Vector Group Ltd (NYSE:VGR) stock decreased -0.05% and finished the last session at $18.35. The EPS of the stock remained -0.10. Company’s market capitalization is $1.79 billion.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was upgraded by stock analysts at Thomson Reuters/Verus from a “hold” rating to a “buy” rating in a report issued on Monday, Analyst Ratings.Net reports. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock opened at $12.20 in last trading session and closed at $12.17. The 52 week range of the stock is $1.12 – $12.35 and the day range was $11.66 – $12.35.
NetScout Systems, Inc. (NASDAQ:NTCT) updated its FY14 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.48-1.50 for the period, compared to the Thomson Reuters consensus estimate of $1.45, Analyst Ratings Net reports. The company issued revenue guidance of $392-395, compared to the consensus revenue estimate of $390.91 million. NetScout Systems, Inc. (NASDAQ:NTCT) stock advanced 14.36% and finished the last session at $36.48. The EPS of the stock remained 0.97. Company’s market capitalization is $1.52 billion.